BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23030583)

  • 1. Immunohistological expression of HIF-1α, GLUT-1, Bcl-2 and Ki-67 in consecutive biopsies during chemoradiotherapy in patients with rectal cancer.
    Havelund BM; Sørensen FB; Pløen J; Lindebjerg J; Spindler KL; Jakobsen A
    APMIS; 2013 Feb; 121(2):127-38. PubMed ID: 23030583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Oncol Rep; 2012 Sep; 28(3):855-61. PubMed ID: 22711167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer.
    Havelund BM; Sørensen FB; Lindebjerg J; Spindler KL; Jakobsen A
    Anticancer Res; 2011 May; 31(5):1559-65. PubMed ID: 21617210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.
    Suzuki T; Sadahiro S; Tanaka A; Okada K; Kamata H; Kamijo A; Murayama C; Akiba T; Kawada S
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1232-8. PubMed ID: 23158058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors.
    Korkeila EA; Sundström J; Pyrhönen S; Syrjänen K
    Anticancer Res; 2011 Dec; 31(12):4529-35. PubMed ID: 22199327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of CD133 and hypoxia inducible factor-1α gene expression in rectal cancer after preoperative chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Koike Y; Fujikawa H; Inoue Y; Miki C; Kusunoki M
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):323-32. PubMed ID: 20970309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
    Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
    Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative radiotherapy downregulates the nuclear expression of hypoxia-inducible factor-1alpha in rectal cancer.
    Korkeila E; Jaakkola PM; Syrjänen K; Sundström J; Pyrhönen S
    Scand J Gastroenterol; 2010 Mar; 45(3):340-8. PubMed ID: 20001759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of tissue ischemia on biomarker expression in colorectal cancer.
    Havelund BM; Olsen DA; Andersen RF; Spindler KL; Brandslund I; Jakobsen A; Soerensen FB
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):298-307. PubMed ID: 23060299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.
    Chang HJ; Jung KH; Kim DY; Jeong SY; Choi HS; Kim YH; Sohn DK; Yoo BC; Lim SB; Kim DH; Ahn JB; Kim IJ; Kim JM; Yoon WH; Park JG
    Hum Pathol; 2005 Apr; 36(4):364-71. PubMed ID: 15891997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
    Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
    Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
    Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
    Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
    Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of significance of Hypoxia Inducible Factor-1α, Glucose Transporter-1 and Carbonic Anhydrase IX in rectal cancer after preoperative chemoradiotherapy.
    Vitoratou DI; Tolia M; Liakos P; Tsoukalas N; Giaginis C; Nikolaou M; Nikolaou G; Rigas G; Psarianos K; Lioupis A; Kyrgias G
    J BUON; 2019; 24(2):456-463. PubMed ID: 31127991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of HIF-1alpha expression in patients with esophageal cancer treated with concurrent chemoradiotherapy.
    Ogawa K; Chiba I; Morioka T; Shimoji H; Tamaki W; Takamatsu R; Nishimaki T; Yoshimi N; Murayama S
    Anticancer Res; 2011 Jun; 31(6):2351-9. PubMed ID: 21737664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of hypoxia inducible factor-1α and correlated target genes in human laryngeal carcinoma].
    XU O; LI XM; WANG MX; QU YT; LU XY; SHAN CG; SUN QJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):330-3. PubMed ID: 22800355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT; Cai ZM; Li NC; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
    Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
    BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
    Shioya M; Takahashi T; Ishikawa H; Sakurai H; Ebara T; Suzuki Y; Saitoh J; Ohno T; Asao T; Kuwano H; Nakano T
    J Radiat Res; 2011; 52(6):821-7. PubMed ID: 22104271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
    Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
    Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.